Islet transplantation at the Diabetes Research Institute Japan

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 15, Issue 3, 2008, Pages 278-283

  Noguchi, Hirofumi ^a,b,c   Matsumoto, Shinichi ^a,b,d  

^a Diabetes Research Institute Japan   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Ductal injection; Iodixanol based purification; Islet transplantation; Living donor; M Kyoto solution; Non heart beating donor

Indexed keywords

BASILIXIMAB; ENZYME; HEMOGLOBIN A1C; IODIXANOL; LIBERASE; MMF; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PERFLUORO COMPOUND; RAPAMYCIN; TACROLIMUS; ULINASTATIN; UNIVERSITY OF WISCONSIN SOLUTION;

BALLOON CATHETER; CADAVER DONOR; CELL ISOLATION; CLINICAL PROTOCOL; COOLING; GRAFT PRESERVATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; JAPAN; KIDNEY PANCREAS TRANSPLANTATION; LIVING DONOR; METHODOLOGY; NONHUMAN; ORGAN PRESERVATION; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; PURIFICATION; REVIEW; TREATMENT OUTCOME; VEIN CATHETERIZATION;

DIABETES MELLITUS, TYPE 1; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; JAPAN; LIVING DONORS; ORGAN PRESERVATION; TISSUE AND ORGAN PROCUREMENT;

EID: 44949151783     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00534-007-1263-0     Document Type: Review

References (58)

1. Boyle JP, Honeycutt AA, Narayan KM, Hoerger TJ, Geiss LS, Chen H, et al. Projection of diabetes burden through 2050: Impact of changing demography and disease prevalence in the US. Diabetes Care 2001;24:1936-1940.
2. DCCT Research Group. Diabetes control and complications trial (DCCT). Update. Diabetes Care 1990;13:427-433.
3. DCCT Research Group. Adverse events and their association with treatment regimens in the Diabetes Control and Complications Trial. Diabetes Care 1995;18:1415-1427.
4. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000;343:230-238.
5. Ryan EA, Lakey JR, Rajotte RV, Korbutt GS, Kin T, Imes S, et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton Protocol. Diabetes 2001;50:710-719.
6. Matsumoto S, Okitsu T, Iwanaga Y, Noguchi H, Nagata H, Yonekawa Y, et al. Insulin independence after living-donor distal pancreatectomy and islet allotransplantation. Lancet 2005;365:1642-1644.
7. Najarian JS, Sutherland DE, Matas AJ, Steffes MW, Simmons RL, Goetz FC. Human islet transplantation: A preliminary report. Transplant Proc 1977;9:233-236.
8. Ricordi C, Strom TB. Clinical islet transplantation: Advances and immunological challenges. Nat Rev Immunol 2004;4:259-268.
9. Matsumoto S, Tanaka K. Pancreatic islet cell transplantation using non-heart-beating donors (NHBDs). J Hepatobiliary Pancreat Surg 2005;12:227-230.
10. Matsumoto S, Tanaka K, Strong DM, Reems JA. Efficacy of human islet isolation from the tail section of the pancreas for the possibility of living donor islet transplantation. Transplantation 2004;78:839-843.
11. Matsumoto S, Okitsu T, Iwanaga Y, Noguchi H, Nagata H, Yonekawa Y, et al. successful islet transplantation from nonheartbeating donor pancreata using modified Ricordi islet isolation method. Transplantation 2006;82:460-465.
12. Rother KI, Harlan DM. Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus. J Clin Invest 2004;114:877-883.
13. Noguchi H, Matsushita M, Okitsu T, Moriwaki A, Tomizawa K, Kang S, et al. A new cell-permeable peptide allows successful allogeneic islet transplantation in mice. Nat Med 2004;10:305-309.
14. Noguchi H, Nakai Y, Matsumoto S, Kawaguchi M, Ueda M, Okitsu T, et al. Cell permeable peptide of JNK inhibitor prevents islet apoptosis immediately after isolation and improves islet graft function. Am J Transplant 2005;5:1848-1855.
15. Noguchi H, Matsumoto S. Protein transduction technology offers a novel therapeutic approach for diabetes. J Hepatobiliary Pancreat Surg 2006;13:306-313.
16. Nagata H, Matsumoto S, Okitsu T, Iwanaga Y, Noguchi H, Yonekawa Y, et al. Procurement of the human pancreas for pancreatic islet transplantation from marginal cadaver donors. Transplantation 2006;82:327-331.
17. Kato M, Mizutani K, Hattori R, Kinukawa T, Uchida K, Hoshinaga K, et al. In situ renal cooling for kidney transplantation from non-heart-beating donors. Transplant Proc 2000;32:1608-1610.
18. Sawada T, Matsumoto I, Nakano M, Kirchhof N, Sutherland DE, Hering BJ. Improved islet yield and function with ductal injection of University of Wisconsin solution before pancreas preservation. Transplantation 2003;75:1965-1969.
19. Yonekawa Y, Matsumoto S, Okitsu T, Arata T, Iwanaga Y, Noguchi H, et al. Effective islet isolation method with extremely high islet yields from adult pigs. Cell Transplant 2005;14:757-762.
20. Matsumoto S, Rigley TH, Reems JA, Kuroda Y, Stevens RB. Improved islet yields from Macaca nemestrina and marginal human pancreata after two-layer method preservation and endogenous trypsin inhibition. Am J Transplant 2003;3:53-63.
21. Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW. Automated method for isolation of human pancreatic islets. Diabetes 1988;37:413-420.
22. Munn SR, Kaufman DB, Field MJ, Viste AB, Sutherland DE. Cold-storage preservation of the canine and rat pancreas prior to islet isolation. Transplantation 1989;47:28-31.
23. Noguchi H, Ueda M, Hayashi S, Kobayashi N, Okitsu T, Iwanaga Y, et al. Ductal injection of preservation solution increases islet yields in islet isolation and improves islet graft function. Cell Transplant 2008;17:69-81.
24. Noguchi H, Iwanaga Y, Okitsu T, Nagata H, Yonekawa Y, Matsumoto S. Evaluation of islet transplantation from non-heart beating donors. Am J Transplant 2006;6:2476-2482.
25. Matsumoto S, Kuroda Y. Perfluorocarbon for organ preservation before transplantation. Transplantation 2002;74:1804-1809.
26. Matsumoto S, Kuroda Y, Hamano M, Kim Y, Suzuki Y, Ku Y, et al. Direct evidence of pancreatic tissue oxygenation during preservation by the two-layer method. Transplantation 1996;62:1667-1670.
27. Matsumoto S, Kandaswamy R, Sutherland DE, Hassoun AA, Hiraoka K, Sageshima J, et al. Clinical application of the twolayer (University of Wisconsin solution/perfluorochemical plus O2) method of pancreas preservation before transplantation. Transplantation 2000;70:771-774.
28. Matsumoto S, Qualley SA, Goel S, Hagman DK, Sweet IR, Poitout V, et al. Effect of the two-layer (University of Wisconsin solution-perfluorochemical plus O2) method of pancreas preservation on human islet isolation, as assessed by the Edmonton Isolation Protocol. Transplantation 2002;74:1414-1419.
29. Hering BJ, Matsumoto I, Sawada T, Nakano M, Sakai T, Kandaswamy R, et al. Impact of two-layer pancreas preservation on islet isolation and transplantation. Transplantation 2002;74:1813-1816.
30. Matsumoto S, Fujino Y, Suzuki Y, Tanioka Y, Muramatsu S, Sugimoto T, et al. Evidence of protein synthesis during resuscitation of ischemically damaged canine pancreas by the two-layer method. Pancreas 2000;20:411-414.
31. Tanioka Y, Kuroda Y, Kim Y, Matsumoto S, Suzuki Y, Ku Y, et al. The effect of ouabain (inhibitor of an ATP-dependent Na+/K+ pump) on the pancreas graft during preservation by the two-layer method. Transplantation 1996;62:1730-1734.
32. Tojimbara T, Wicomb WN, Garcia-Kennedy R, Burns W, Hayashi M, Collins G, et al. Liver transplantation from non-heart beating donors in rats: influence of viscosity and temperature of initial flushing solutions on graft function. Liver Transpl Surg 1997;3:39-45.
33. Omasa M, Hasegawa S, Bando T, Hanaoka N, Yoshimura T, Nakamura T, et al. Application of ET-Kyoto solution in clinical lung transplantation. Ann Thorac Surg 2004;77:338-339.
34. Chen F, Fukuse T, Hasegawa S, Bando T, Hanaoka N, Kawashima M, et al. Effective application of ET-Kyoto solution for clinical lung transplantation. Transplant Proc 2004;36:2812-2815.
35. Wu SF, Suzuki Y, Kitahara AK, Wada H, Nishimura Y. Skin flap storage with intracellular and extracellular solutions containing trehalose. Ann Plast Surg 1999;43:289-294.
36. Belzer FO, Southard JH. Organ preservation and transplantation. Prog Clin Biol Res 1986;224:291-303.
37. Fujimoto S, Mukai E, Hamamoto Y, Takeda T, Takehiro M, Yamada Y, et al. Prior exposure to high glucose augments depolarization-induced insulin release by mitigating the decline of ATP level in rat islets. Endocrinology 2002;143:213-221.
38. Robertson GS, Chadwick D, Thirdborough S, Swift S, Davies J, James R, et al. Human islet isolation-a prospective randomized comparison of pancreatic vascular perfusion with hyperosmolar citrate or University of Wisconsin solution. Transplantation 1993;56:550-553.
39. Contractor HH, Johnson PR, Chadwick DR, Robertson GS, London NJ. The effect of UW solution and its components on the collagenase digestion of human and porcine pancreas. Cell Transplant 1995;4:615-619.
40. Noguchi H, Ueda M, Nakai Y, Iwanaga Y, Okitsu T, Nagata H, et al. Modified two-layer preservation method (M-Kyoto/PFC) improves islet yields in islet isolation. Am J Transplant 2006;6:496-504.
41. Noguchi H, Ueda M, Hayashi S, Kobayashi N, Nagata H, Iwanaga Y, et al. Comparison of M-Kyoto solution and histidinetryptophan-ketoglutarate solution with a trypsin inhibitor for pancreas preservation in islet transplantation. Transplantation 2007;84:655-658.
42. Ricordi C. Islet transplantation: A brave new world. Diabetes 2003;52:1595-603.
43. Balamurugan AN, Chang Y, Fung JJ, Trucco M, Bottino R. Flexible management of enzymatic digestion improves human islet isolation outcome from sub-optimal donor pancreata. Am J Transplant 2003;3:1135-1142.
44. van der Burg MP, Basir I, Bouwman E. No porcine islet loss during density gradient purification in a novel iodixanol in University of Wisconsin solution. Transplant Proc 1998;30:362-363.
45. Ichii H, Pileggi A, Molano RD, Baidal DA, Khan A, Kuroda Y, et al. Rescue purification maximizes the use of human islet preparations for transplantation. Am J Transplant 2005;5:21-30.
46. Baidal DA, Froud T, Ferreira JV, Khan A, Alejandro R, Ricordi C. The bag method for islet cell infusion. Cell Transplant 2003;12:809-813.
47. Noguchi H, Matsumoto S, Matsushita M, Kobayashi N, Tanaka K, Matsui H, et al. Immunosuppression for islet transplantation. Acta Med Okayama 2006;60:71-76.
48. Markmann JF, Deng S, Desai NM, Huang X, Velidedeoglu E, Frank A, et al. The use of non-heart-beating donors for isolated pancreatic islet transplantation. Transplantation 2003;75:1423-1429.
49. Noguchi H, Yamada Y, Okitsu T, Iwanaga Y, Nagata H, Kobayashi N, et al. Secretory Unit of Islet in Transplantation (SUIT) and Engrafted Islet Rate (EIR) indexes are useful for evaluating single islet transplantation. Cell Transplant 2008;17:121-128.
50. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005;54:2060-2069.
51. Noguchi H, Kaneto H, Weir GC, Bonner-Weir S. PDX-1 protein containing its own antennapedia-like protein transduction domain can transduce pancreatic duct and islet cells. Diabetes 2003;52:1732-1737.
52. Noguchi H. Activation of c-Jun NH 2 -terminal kinase during islet isolation. Endocr J 2007;54:169-176.
53. Noguchi H. Stem cells for the treatment of diabetes. Endocr J 2007;54:7-16.
54. Noguchi H, Bonner-Weir S, Wei FY, Matsushita M, Matsumoto S. BETA2/ NeuroD protein can be transduced into cells due to an arginine-and lysine-rich sequence. Diabetes 2005;54:2859-2866.
55. Noguchi H, Nakai Y, Ueda M, Masui Y, Futaki S, Kobayashi N, et al. Activation of c-Jun NH(2)-terminal kinase (JNK) pathway during islet transplantation and prevention of islet graft loss by intraportal injection of JNK inhibitor. Diabetologia 2007;50:612-619.
56. Noguchi H, Matsumoto S. Protein transduction technology: A novel therapeutic perspective. Acta Med Okayama 2006;60:1-11.
57. Noguchi H, Ueda M, Matsumoto S, Kobayashi N, Hayashi S. BETA2/NeuroD protein transduction requires cell surface heparan sulfate proteoglycans. Hum Gene Ther 2007;18:10-17.
58. Noguchi H, Xu G, Matsumoto S, Kaneto H, Kobayashi N, Bonner-Weir S, et al. Induction of pancreatic stem/progenitor cells into insulin-producing cells by adenoviral-mediated gene transfer technology. Cell Transplant 2006;15:929-938.